Marc Vaillancourt

Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease

Daniel Lamarre, G Croteau, Elizabeth Wardrop et al. · Antimicrobial Agents and Chemotherapy · 1997 · 74 citations · Full text

Potent Inhibitor, Medicine, Immunology +13

The HIV Type 1 Protease Inhibitor Saquinavir Can Select for Multiple Mutations that Confer Increasing Resistance

Marc Vaillancourt, David M. Irlbeck, Terri Smith et al. · AIDS Research and Human Retroviruses · 1999 · 28 citations

Protease Inhibitor Saquinavir, Multiple Mutations, Human Retrovirus +14

Cyclosporine Reduction in the Presence of Everolimus: 3-Month Data From a Canadian Pilot Study of Maintenance Cardiac Allograft Recipients

Heather J. Ross, Peter W. Pflugfelder, Haissam Haddad et al. · The Journal of Heart and Lung Transplantation · 2008 · 27 citations

3-Month Data, Heart Failure, Transplantation +9

Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study

Heather J. Ross, Peter W. Pflugfelder, Haissam Haddad et al. · Transplant International · 2009 · 25 citations

Design and synthesis of a new Sialyl Lewis X Mimetic: How selective are the selectin receptors?

Marc De Vleeschauwer, Marc Vaillancourt, Nathalie Goudreau et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 21 citations · Full text

Combinatorial Chemistry, Heterocyclic, Biochemistry +5